Nkarta's blood cancer CAR stalls again, with falling response rate forcing it out of...

[cafead]

via Nkarta’s CAR NK blood cancer candidate has again stalled after making a speedy start. The response rate fell away sharply in the latest update, mirroring what happened in an earlier cohort and driving the cell therapy developer to mothball the program.

article source